UTMB Research on Severe Asthma (UROSA) Study
NCT02264691 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 131
Last updated 2016-10-26
Summary
To identify and understand biologic aspects of severe asthma compared to subjects with mild to moderate asthma and subjects without asthma (normal or healthy volunteers).
Conditions
Sponsors & Collaborators
-
The University of Texas Medical Branch, Galveston
lead OTHER
Principal Investigators
-
William Calhoun, M.D. · UTMB
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2016-07-31
- Completion
- 2016-07-31
Countries
- United States
Study Locations
More Related Trials
-
Identification of Serum Biomarkers for CD15+ Hypodense Neutrophils in Severe Asthma
NCT02659618 ·Status: COMPLETED
-
Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)
NCT06472310 ·Status: RECRUITING
-
Study of Omalizumab in Moderate to Severe Bronchial Asthma
NCT00232050 ·Status: COMPLETED ·Phase: PHASE3
-
Cohort Analysis of Clinical and Biological Severe Childhood Asthma
NCT02114034 ·Status: ACTIVE_NOT_RECRUITING
-
Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients
NCT00482508 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled Asthma
NCT01007149 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils
NCT02501629 ·Status: COMPLETED ·Phase: PHASE3
-
Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects
NCT06015256 ·Status: RECRUITING ·Phase: NA
-
Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Biologic Therapy, a Post Authorization Safety Study
NCT04991805 ·Status: COMPLETED
-
Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma.
NCT00219323 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
NCT04520165 ·Status: ACTIVE_NOT_RECRUITING
-
BenRalizumab Effect on Airway Remodeling in Severe asTHma
NCT06288516 ·Status: RECRUITING ·Phase: PHASE4
-
Community Based Study of Adult Onset Asthma
NCT00005544 ·Status: COMPLETED
-
Alveolar and Serum sRAGE in Severe Asthma in Children
NCT05364996 ·Status: RECRUITING
-
Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma
NCT00264849 ·Status: COMPLETED ·Phase: PHASE4
-
Defining the Severe Paediatric Asthma Endotype
NCT04680117 ·Status: COMPLETED ·Phase: NA
-
A Study of Step-up in Bronchial Asthma as a New End Point in Asthma Control (SURFE)
NCT05632081 ·Status: RECRUITING
-
Severe Asthma Research Program - Wake Forest University
NCT01750411 ·Status: COMPLETED
-
Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients
NCT04181190 ·Status: COMPLETED
-
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
NCT01545440 ·Status: COMPLETED ·Phase: PHASE2
-
Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity
NCT00217854 ·Status: COMPLETED ·Phase: NA
-
Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database
NCT05136547 ·Status: COMPLETED
-
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
NCT02537691 ·Status: COMPLETED ·Phase: PHASE4
-
Similarities and Differences of Biological Therapies for Severe Asthma.
NCT04665141 ·Status: UNKNOWN
-
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
NCT03186209 ·Status: COMPLETED ·Phase: PHASE3